Cynata Therapeutics Limited (CYP) is an Australian clinical-stage stem cell and regenerative medicine company focused on the development of therapies based on Cymerus, a proprietary therapeutic stem cell platform technology. Cynata’s product candidate CYP-001 met all clinical endpoints and demonstrated positive safety and efficacy data for the treatment of steroid-resistant acute graft-versus-host disease (GvHD) in a Phase 1 trial.
Cynata Therapeutics Limited operators in Health Care sector and under industry of Biotechnology. The company website is: http://www.cynata.com.
You can also check out dividend history for similar stocks in the same sector as follows:
CYP Dividend Dates
Please click the table header to sort the data.
No Dividend Dates Found